9:40 am
Featuring Melissa Lavasani, Tom Zuber, Ethan Nadelmann, Shayla Love, Leonard Pickard, Courtney Barnes, Esq., Elizabeth Steiner Hayward.
Where are we now? Where are we heading?
Explore the Schedule
Spread across two days, taking place on the elegant stage of the Adrienne Arsht Center, Wonderland: 2021 offered a comprehensive experience of the psychedelic medicine industry. From leading investors to indigenous elders, presentations of cutting-edge research to stories of healing, the Wonderland: 2021 agenda had it all.
Know what you're looking for? Jump to a specific day
10:30 am
Featuring Dr. Suran Goonatilake, OBE.
To bring a drug to market used to cost $1B-$2B and 10 years. With AI-driven drug discovery, pre-clinical testing for entirely novel drug candidates can be started within 50 days. We present our work in screening candidate psychedelic drug compounds and the discovery of novel compounds, through the power of AI.
10:55 am
Featuring Olga Chernoloz, PhD.
11:20 am
Featuring Daniel Carcillo, Mike Tyson, Amanda Siebert.
A fireside chat between Mike Tyson and Daniel Carcillo.
12:10 pm
Featuring Brett Frantz, Dina Burkitbayeva, Nancy Fechnay, Henri Sant-Cassia, Brom Rector, Lindsay Hoover, Sylvia Benito.
12:45 pm
Featuring James Lanthier, Joseph Araujo.
1:00 pm
Featuring John Atanasio.
1:15 pm
Featuring Dr. Roger McIntyre.
2:00 pm
Featuring Steven Holdt, Paul F. Austin, Gregory Ferenstein, Dr. Erica Zelfand, ND, Natasha de Jong, Judy Blumstock.
Does microdosing improves focus, creativity and productivity? But are the touted effects fact or fiction?
2:40 pm
Featuring Greg McKee, Jackie von Salm, Abraham Dreazen, Ahmad Doroudian, Najla Guthrie, Sherry Boodram.
Just how far can we go with psychedelic medicine; could it unlock the keys to a longer life? Are compounds hiding in plain sight?
3:10 pm
Featuring Dillan DiNardo, James Kuo, MD, MBA, Dr. Joseph Tucker, Joel Stanley, Olga Chernoloz, PhD, Maria Velkova, Debra Borchardt.
Let’s talk about advancements in R&D, trial designs, new compounds, regulatory affairs, patient engagement, and new forms of partnerships.
3:30 pm
Featuring Laurence W. Zeifman, Patrick Trucchio, Juan Cappello, Yeji Jesse Lee, Edward Zhong.
Psychedelic companies have been getting large valuations very quickly. With ATAI at a 2.27B market cap, Compass Pathways at 1.46B, and GHRS 691M many people are left wondering how realistic these numbers are. By talking to experts on all sides of the story: sell-side research analyst, independent financial consultant, and buy-side investment analyst, we should be able to gain more understanding of what these valuations mean, how they are calculated, and what makes a company in the psychedelic space potentially attractive investment.
3:30 pm
Featuring Kelsey Ramsden, MBA, Olivia Mannix, Nicolle Hodges, Todd Shapiro, Sarah Hashkes.
An important conversation around sex & psychedelics. There is immense potential in the intersection of these hot topics but also a lot of safety issues that are important to talk about openly.
4:00 pm
Featuring Dr. Robin Carhart-Harris, PhD.
4:40 pm
Featuring Payton Nyquvest, Evan Lewis.
5:00 pm
Featuring Dr. Abid Nazeer, M.D., FASAM, Jay Godfrey, Kathryn Walker, Mareesa Stertz, Christopher Dawson, Dr. Julie Holland, Brittany Nelson.
Taking a deeper look at Clinics & Retreats. How does the model work and why is it needed?
5:50 pm
Featuring Rick Doblin, Patrick Moher, Klee Irwin.
6:10 pm
Featuring Keith Ferrazzi, Spencer Hawkswell, Hanifa Nayo Washington, Joe Moore, Jan Hardorp, Rebecca Lee.
9:10 am
Featuring Deborah Mash, PhD, David Meiri, Boaz Wachtel, Talia Eisenberg.
9:40 am
Featuring Matthew Johnson.
10:10 am
Featuring Michael Huttner, Cody Shandraw, Richard Skaife, Ken Belotsky, Charlie Finnie, Ryan Zurrer, Liana Sananda Gillooly.
Can consciousness and capitalism co-exist?
11:00 am
Featuring Sylvia Benito, Salim Ismail.
Shamanic protocol for making investment decisions.
11:30 am
Featuring Dustin Robinson, Dr. Julia Mirer, MD, Scott Fisher, Nach Dave, Bonnie Segal.
Hear experts at the interface of policy, research, and business discuss the implications of the work being done in Florida and how you can get involved.
12:00 pm
Featuring Brett Leonard, Richard Skaife, Kelsey Ramsden, MBA, Jeremy Gardner, David Champion, Demian Bellumio, Sarah Hashkes.
Is there a way to keep the beneficial properties of psychedelics medicine without the hallucinogenic side effects by using technology?
12:40 pm
Featuring Riley Cote, Anna Symonds, Josiah Hesse, Ian Mccall, Eben Britton.
1:10 pm
Featuring Del Potter, Helen McCormack, Dr. James Linden, Prof. Keith Murphy, Daniel Robin.
1:25 pm
Featuring Earl Blumenauer.
2:00 pm
Featuring Ben Sessa, Professor David Nutt, Amanda Siebert.
2:30 pm
Featuring Zappy Zapolin, Lamar Odom, Dr. Roger McIntyre, Nicolle Hodges, Dr. Michelle Weiner, DO, MPH.
Join NBA champion and ketamine patient Lamar Odom, along with foremost expert in ketamine treatment Dr. Roger McIntyre, and Psychedelic Concierge and filmmaker Zappy Zapolin for a panel discussion about the rising awareness of ketamine‘s transformative treatment for depression, anxiety, PTSD, additction and other mental health disorders.
3:00 pm
Featuring Dr. Marvin S. Hausman, MD, Kelsey Ramsden, MBA, Amy Emerson, Jon Kostakopoulos, Natan Ponieman, Dr. Jeeshan Chowdhury, PhD.
Can psychedelic-assisted psychotherapy create a truly revolutionary paradigm shift in psychiatry?
3:40 pm
Featuring Dr. Lynn Marie Morski, MD, JD, Sophie-Charlotte Adler, Capt Kimberly Juroviesky, CAPT, USAF, Gigi Kuo, Olivia Mannix, Jemie Sae Koo.
As psychedelic medicines become more mainstream, how will these new therapies fit into our current medical paradigm?
4:30 pm
Featuring Jayashree Mitra, Sharan Sidhu, Yeji Jesse Lee, Graham Pechenik, Esq.
Is the corporate domination of the industry a significant threat or an opportunity to decrease the stigma and take psychedelic medicine into mainstream healthcare?
5:00 pm
Featuring Amanda Siebert, Susan Chapelle, eMBA, Sandor Iron Rope, K'uychi Florez, Max Montrose, Joseph Mays.
Addressing the need for psychedelic equity, access, and affordability.
5:30 pm
Featuring Marcus and Amber Capone, Sasha Sisko, Anne Philippi, Rachel Yehuda, Brandon Weiss, Arron Victory.
The Heroic Dose panel explores the potential of the psychedelics rather than opioids that can acutely save lives and decrease the acute process that starts PTSD in Veterans and first responders, reduce graduation of acute pain into chronic pain and reduce opioid addiction, help prevent suicides in the long run, given the clear correlation with all of these factors.